Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-07-01-Speech-2-153"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-07-01"^^xsd:date2
dcterms:Is Part Of	lp_eu:Strengthening the European pharmaceutical industry in the interest of patients – proposals for action2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20030701.6.2-153"2
lpv:hasSubsequent	lp_eu:2003-07-01-Speech-2-1542
lpv:speaker	lp:Anne Ferreira2
lpv:spokenAs	substitute; AGRI (2002-01-17--2004-07-19)3 unknown; Parti socialiste (1999-12-18--2004-07-19)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; Delegation for relations with South Africa (2002-02-07--2004-07-19)3 member; PES (1999-12-18--2004-07-19)3 substitute; Delegation to the EU-Slovenia Joint Parliamentary Committee (2002-02-07--2004-04-30)3
lpv:translated text	"Commissioners, among your numerous proposals, you referred to the added value of medicines. I believe that this is a crucial point. A large number of new medicines now coming onto the market are, unfortunately, rarely innovative. What practical measures do you envisage for encouraging industry to produce not only new but also innovative medicines? You also raised the issue of the European computer portal. New Zealand, for whom I have appointed myself spokesperson, is currently working on just such a system and wonders whether our contribution to this system will be medicine-centred or disease-centred and, in the latter case, whether the answers provided will revolve around medicinal therapy or whether other, replacement therapies will be proposed on these sites."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph